Alteogen Inc
KOSDAQ:196170

Watchlist Manager
Alteogen Inc Logo
Alteogen Inc
KOSDAQ:196170
Watchlist
Price: 458 000 KRW 0.33% Market Closed
Market Cap: 24.5T KRW

Relative Value

The Relative Value of one Alteogen Inc stock under the Base Case scenario is hidden KRW. Compared to the current market price of 458 000 KRW, Alteogen Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Alteogen Inc Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
19
vs Industry
9
Median 3Y
88.2
Median 5Y
78.9
Industry
7.9
Forward
92.7
vs History
38
vs Industry
0
Median 3Y
239.2
Median 5Y
150.3
Industry
24
Forward
199
vs History
41
vs Industry
0
Median 3Y
281
Median 5Y
187.4
Industry
21.6
vs History
20
vs Industry
100
Median 3Y
-32.3
Median 5Y
-32.3
Industry
23.7
vs History
15
vs Industry
0
Median 3Y
55.3
Median 5Y
23.1
Industry
3.4
vs History
19
vs Industry
7
Median 3Y
87
Median 5Y
77
Industry
8.3
Forward
91.2
vs History
50
vs Industry
3
Median 3Y
202.5
Median 5Y
203.6
Industry
10.3
vs History
19
vs Industry
0
Median 3Y
-69.1
Median 5Y
-124.3
Industry
6.7
Forward
183.4
vs History
19
vs Industry
100
Median 3Y
-62.9
Median 5Y
-110.8
Industry
7.2
Forward
187.4
vs History
41
vs Industry
0
Median 3Y
276.6
Median 5Y
184.1
Industry
8.2
vs History
7
vs Industry
Median 3Y
-39.8
Median 5Y
-65.4
Industry
6.7
vs History
17
vs Industry
2
Median 3Y
61.6
Median 5Y
74.3
Industry
5.7

Multiples Across Competitors

Competitors Multiples
Alteogen Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
KR
Alteogen Inc
KOSDAQ:196170
24.5T KRW 154.9 259.6 307.7 319.3
FR
Pharnext SCA
OTC:PNEXF
6T USD 34 071 784.8 -161 938.1 -196 644.6 -194 400.6
US
Abbvie Inc
NYSE:ABBV
398B USD 6.7 169.3 16.4 23.2
US
Amgen Inc
NASDAQ:AMGN
174.6B USD 4.9 25.1 18.1 18.1
US
Gilead Sciences Inc
NASDAQ:GILD
151B USD 5.2 18.6 12.5 12.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
113B USD 9.8 31.3 23 24
US
Epizyme Inc
F:EPE
94.1B EUR 2 067.7 -527.6 -574.5 -559.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
74.8B USD 5.3 16.4 15.5 17.6
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
57.1B USD 18.3 1 347.2 177.4 215.2
AU
CSL Ltd
ASX:CSL
89.8B AUD 3.8 19.9 13.3 16.6
NL
argenx SE
XBRU:ARGX
48B EUR 15.6 36.6 62.9 64.7
P/S Multiple
Revenue Growth P/S to Growth
KR
Alteogen Inc
KOSDAQ:196170
Average P/S: 3 097 643.4
154.9
112%
1.4
FR
Pharnext SCA
OTC:PNEXF
34 071 784.8
N/A N/A
US
Abbvie Inc
NYSE:ABBV
6.7
9%
0.7
US
Amgen Inc
NASDAQ:AMGN
4.9
5%
1
US
Gilead Sciences Inc
NASDAQ:GILD
5.2
4%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
9.8
10%
1
US
E
Epizyme Inc
F:EPE
2 067.7
N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.3
6%
0.9
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
18.3
46%
0.4
AU
CSL Ltd
ASX:CSL
3.8
5%
0.8
NL
argenx SE
XBRU:ARGX
15.6
49%
0.3
P/E Multiple
Earnings Growth PEG
KR
Alteogen Inc
KOSDAQ:196170
Average P/E: 213.8
259.6
117%
2.2
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -161 938.1 N/A N/A
US
Abbvie Inc
NYSE:ABBV
169.3
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
25.1
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
18.6
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
31.3
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -527.6 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.4
9%
1.8
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 347.2
N/A N/A
AU
CSL Ltd
ASX:CSL
19.9
11%
1.8
NL
argenx SE
XBRU:ARGX
36.6
40%
0.9
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
KR
Alteogen Inc
KOSDAQ:196170
Average EV/EBITDA: 71.9
307.7
196%
1.6
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -196 644.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.4
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
18.1
11%
1.6
US
Gilead Sciences Inc
NASDAQ:GILD
12.5
7%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23
16%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -574.5 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
15.5
11%
1.4
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
177.4
N/A N/A
AU
CSL Ltd
ASX:CSL
13.3
8%
1.7
NL
argenx SE
XBRU:ARGX
62.9
807%
0.1
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
KR
Alteogen Inc
KOSDAQ:196170
Average EV/EBIT: 79
319.3
205%
1.6
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 400.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.2
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
18.1
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.5
12%
1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -559.2 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.6
13%
1.4
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
215.2
N/A N/A
AU
CSL Ltd
ASX:CSL
16.6
11%
1.5
NL
argenx SE
XBRU:ARGX
64.7
N/A N/A